Ad
related to: merck pharmaceuticals stock pricedirexion.com has been visited by 100K+ users in the past month
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Bull & Bear 3X ETFs
Search results
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 6 days agoThe Zacks Large Cap Pharmaceuticals industry, to which Merck belongs, has gained 1.1% over this...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 1 day agoMerck & Co., Inc. Price and Consensus Merck & Co., Inc. price-consensus-chart | Merck & Co., Inc ...
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 1 day agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 6 days agoThe company's stock felt the pressure from a downturn in COVID-19 product sales last year...is known for its strong pricing power, with cancer drugs...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 hours ago0807 GMT – Germany’s Merck KGaA gave quantitative 2024 guidance for the first time and this, together with first-quarter results, affirms its expectation...
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...
The Fiscal Times via Yahoo Finance· 6 days ago... drug companies that make the 10 medications whose prices are currently being negotiated by...
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Zacks via Yahoo Finance· 7 days agoThe future development of IV ganaxolone in refractory status epilepticus will be assessed following...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoMerck just won approval for the first drug that treats an underlying cause of PAH, Winrevair....
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 5 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 days agoThe tech firm and the stock are proven winners. Now might be the time for investors to heed...
